Atreca, Inc.
DelistedCIK 1532346fmd_17JXYGPRF0CNPJ8VQAH7B18SPYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2023, 22 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Research and development | 33 | 55 | 62 | 78 | 67 |
| Total operating expenses | 40 | 73 | 89 | 110 | 99 |
| Interest expense | 0 | 0 | 0 | 0 | – |
| Interest and investment income | 1 | 3 | 1 | 0 | 1 |
| Income before taxes | (38) | (67) | (86) | (109) | (97) |
| Income tax expense | (0) | 0 | 0 | 0 | – |
| Net income from continuing operations | (38) | (67) | (86) | (109) | – |
| Net income | (38) | (67) | (86) | (109) | (97) |